Reduced Duration of Postchikungunya Musculoskeletal Pain in Rheumatological Patients Treated with Biologicals

Journal of Tropical Medicine
Carlos A A de BritoAngela L B P Duarte

Abstract

Chikungunya fever (CHIK) has caused important epidemic outbreaks in the Americas, with musculoskeletal involvement being the main manifestation, causing chronic symptoms in half of the affected patients. This study was performed to evaluate the clinical course of the infection in 168 patients with autoimmune inflammatory disease using biological disease-modifying antirheumatic drugs (bDMARDs), comparing this group with 56 household controls. Anti-CHIKV IgG serology was positive in 42 (25%) of the patients in the bDMARD group and in 15 (27%) of the controls (p=0.79). Of those with positive serology, 32 (76%) and 14 (93%) were symptomatic among subjects in the bDMARD and control groups, respectively (p=0.87). Persistence of musculoskeletal symptoms for more than three months occurred in 64% of the patients in the control group and only in 28% in the bDMARD group (p=0.021), maintaining a statistically significant difference only for users of anti-TNF. This study found that patients affected by chikungunya fever using bDMARDs did not present severe forms or complications in the acute phase of the disease, and patients using anti-TNF biologicals had a lower frequency of chronic joint symptoms than the household controls. This favora...Continue Reading

References

Feb 19, 2003·FEMS Immunology and Medical Microbiology·Alena AtrasheuskayaGeorge Ignatyev
Jan 27, 2004·Current Medical Research and Opinion·Edward Tobinick
Feb 1, 2011·Arthritis and Rheumatism·Ali ZaidSuresh Mahalingam
Sep 27, 2013·BioMed Research International·Iranaia Assunção-MirandaAndrea T Da Poian
Sep 10, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Christophe DelignySerge Arfi
Oct 25, 2014·PloS One·Anuradha VenugopalanArvind Chopra
Nov 25, 2014·Emerging Infectious Diseases·Christine M PratIsabelle Leparc-Goffart
Jan 21, 2017·PLoS Neglected Tropical Diseases·Rivaldo V CunhaJulio Croda
Nov 22, 2017·Revista Da Sociedade Brasileira De Medicina Tropical·Carlos Alexandre Antunes de Brito
Feb 11, 2018·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Fernández-RuizJ Delaloye
Oct 3, 2018·Expert Review of Gastroenterology & Hepatology·Zachary A BormanJean-Frédéric Colombel
Oct 27, 2018·Frontiers in Cellular and Infection Microbiology·Ithallo S B TanabeÊnio J Bassi
Sep 7, 2019·Nature Communications·Claudia P FigueiredoSergio T Ferreira
Mar 3, 2020·The Lancet Infectious Diseases·Justin StebbingPeter Richardson

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Stata

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.